3i Group is a private equity firm based in London, founded in 1945, that specializes in investments across various sectors including infrastructure, healthcare, consumer goods, industrial technology, and business services. The firm focuses on mature companies and provides growth capital, management buyouts, and debt management, primarily targeting investments in Northern Europe, North America, and select markets in Asia. 3i Group typically invests between €5 million and €300 million in companies with enterprise values ranging from €100 million to €500 million. Its investment strategy emphasizes forming close partnerships with portfolio companies, aiming to enhance their capabilities and competitive advantage through expert guidance and a robust international network. The firm manages a diverse portfolio that includes private equity and infrastructure investments, with a significant focus on utilities, transportation, and social infrastructure.
ApaTech Ltd., an ortho-biologics company, produces synthetic bone repair materials. It offers Actifuse, a synthetic bone graft, which creates a material that promotes the formation of bone and increases the volume of bone formed in the graft/host bone composite structures for small void filling and spinal fusion applications. The company also provides ApaPore, a synthetic and porous hydro-xyapatite grafting for the cemented revision of failed total joint arthroplasties for spinal fusions and fracture fixations, as well as for treating bone defects; and Actifuse MIS Bone Graft Delivery System that offers controlled delivery and precise placement for surgeons performing open and minimally invasive procedures, as well as for use in various spinal and orthopedic procedures, including posterolateral fusion, bone void filling, and acetabular cysts. It offers its products through distributors in the United Kingdom, Ireland, Norway, Sweden, Germany, Austria, Spain, Portugal, Italy, Greece, Turkey, Kuwait, Syria, Australia, and New Zealand. ApaTech Ltd. was founded in 2001 and is based in Elstree, the United Kingdom. It has operations in London, the United Kingdom; Foxborough, Massachusetts; and Berlin, Germany.
ApaTech Ltd., an ortho-biologics company, produces synthetic bone repair materials. It offers Actifuse, a synthetic bone graft, which creates a material that promotes the formation of bone and increases the volume of bone formed in the graft/host bone composite structures for small void filling and spinal fusion applications. The company also provides ApaPore, a synthetic and porous hydro-xyapatite grafting for the cemented revision of failed total joint arthroplasties for spinal fusions and fracture fixations, as well as for treating bone defects; and Actifuse MIS Bone Graft Delivery System that offers controlled delivery and precise placement for surgeons performing open and minimally invasive procedures, as well as for use in various spinal and orthopedic procedures, including posterolateral fusion, bone void filling, and acetabular cysts. It offers its products through distributors in the United Kingdom, Ireland, Norway, Sweden, Germany, Austria, Spain, Portugal, Italy, Greece, Turkey, Kuwait, Syria, Australia, and New Zealand. ApaTech Ltd. was founded in 2001 and is based in Elstree, the United Kingdom. It has operations in London, the United Kingdom; Foxborough, Massachusetts; and Berlin, Germany.
ApaTech Ltd., an ortho-biologics company, produces synthetic bone repair materials. It offers Actifuse, a synthetic bone graft, which creates a material that promotes the formation of bone and increases the volume of bone formed in the graft/host bone composite structures for small void filling and spinal fusion applications. The company also provides ApaPore, a synthetic and porous hydro-xyapatite grafting for the cemented revision of failed total joint arthroplasties for spinal fusions and fracture fixations, as well as for treating bone defects; and Actifuse MIS Bone Graft Delivery System that offers controlled delivery and precise placement for surgeons performing open and minimally invasive procedures, as well as for use in various spinal and orthopedic procedures, including posterolateral fusion, bone void filling, and acetabular cysts. It offers its products through distributors in the United Kingdom, Ireland, Norway, Sweden, Germany, Austria, Spain, Portugal, Italy, Greece, Turkey, Kuwait, Syria, Australia, and New Zealand. ApaTech Ltd. was founded in 2001 and is based in Elstree, the United Kingdom. It has operations in London, the United Kingdom; Foxborough, Massachusetts; and Berlin, Germany.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.